Magnitude of Osteoarthritis disadVantage on pEoples liveS

Completed

• Conditions: Osteoarthritis

• Registration Number: NCT01423097
• Lead Sponsor: AstraZeneca

Brief Summary

Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age:

* Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain)

* Characterization of OA diagnosis in patients with self-reported OA

* Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0)

* Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA

* Patient perception of impact of OA in its life and importance given to disease

Detailed Description

Magnitude of Osteoarthritis disadvantage on peoples lives.

Study Timeline

• Study First Submitted: 2011-08-24
• Study First Submitted QC: 2011-08-24
• Study First Posted: 2011-08-25
• Study Start: 2011-09
• Primary Completion: 2011-11
• Study Completion: 2011-11
• Status Verified: 2012-10
• Last Update Submitted: 2012-10-09
• Last Update Posted: 2012-10-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1015

Inclusion Criteria

• Adults over 45 years old with self-reported osteoarthritis

Exclusion Criteria

• NA

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Estimate the prevalence of self-reported osteoarthritis (OA) in adults over 45 years of age by direct interview.	Single interview at the only one patient contact

Secondary Outcome Measures

Name	Time	Method
Impact of self-reported OA in the working abilities, quality of life and functionality using Questionnaire SF-12 v2.0	Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting socio-demographic information through direct interview.	Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting information for intensity of pain through direct interview.	Single interview at the only one patient contact
Characterization of OA diagnosis in patients with self-reported OA by direct interview.	Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting comorbidities information through direct interview.	Single interview at the only one patient contact
Patient perception of impact of OA in its life and importance given to disease by direct interview.	Single interview at the only one patient contact

Trial Locations

Locations (1)

Research Site; 🇵🇹 Queluz Baixo, Barcarena, Portugal